119 related articles for article (PubMed ID: 26086116)
21. Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study.
Vinik AI; Perrot S; Vinik EJ; Pazdera L; Jacobs H; Stoker M; Long SK; Snijder RJ; van der Stoep M; Ortega E; Katz N
BMC Neurol; 2016 Dec; 16(1):251. PubMed ID: 27919222
[TBL] [Abstract][Full Text] [Related]
22. Topical Capsaicin for Treatment of Chronic Neuropathic Pain in Adults.
Crawford P; Xu Y
Am Fam Physician; 2017 Dec; 96(11):Online. PubMed ID: 29431402
[No Abstract] [Full Text] [Related]
23. A randomized controlled trial comparing treatment regimens for acute pain for topical oleoresin capsaicin (pepper spray) exposure in adult volunteers.
Barry JD; Hennessy R; McManus JG
Prehosp Emerg Care; 2008; 12(4):432-7. PubMed ID: 18924005
[TBL] [Abstract][Full Text] [Related]
24. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
25. Piquancy.
Ferner R
BMJ; 2013 May; 346():f2938. PubMed ID: 23674333
[No Abstract] [Full Text] [Related]
26. Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study.
Gálvez R; Navez ML; Moyle G; Maihöfner C; Stoker M; Ernault E; Nurmikko TJ; Attal N
Clin J Pain; 2017 Oct; 33(10):921-931. PubMed ID: 28872473
[TBL] [Abstract][Full Text] [Related]
27. A more pessimistic life orientation is associated with experimental inducibility of a neuropathy-like pain pattern in healthy individuals.
Dimova V; Oertel BG; Kabakci G; Zimmermann M; Hermens H; Lautenbacher S; Ultsch A; Lötsch J
J Pain; 2015 Aug; 16(8):791-800. PubMed ID: 26056011
[TBL] [Abstract][Full Text] [Related]
28. Application of the capsaicin 8% cutaneous patch in neuropathic pain of the head and face: A case series.
Gaul C; Resch S
Cephalalgia; 2015 May; 35(6):545-50. PubMed ID: 25217483
[TBL] [Abstract][Full Text] [Related]
29. Association of bilateral acute anterior uveitis with a capsaicin patch.
Bleuel I; Zinkernagel M; Tschopp M; Tappeiner C
Ocul Immunol Inflamm; 2013 Oct; 21(5):394-5. PubMed ID: 23730925
[TBL] [Abstract][Full Text] [Related]
30. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.
Wallace M; Schulteis G; Atkinson JH; Wolfson T; Lazzaretto D; Bentley H; Gouaux B; Abramson I
Anesthesiology; 2007 Nov; 107(5):785-96. PubMed ID: 18073554
[TBL] [Abstract][Full Text] [Related]
31. Zucapsaicin for the treatment of neuropathic pain.
Sałat K; Jakubowska A; Kulig K
Expert Opin Investig Drugs; 2014 Oct; 23(10):1433-40. PubMed ID: 25171227
[TBL] [Abstract][Full Text] [Related]
32. Posttraumatic and postsurgical neuropathic pain responsive to treatment with capsaicin 8% topical patch.
Zis P; Apsokardos A; Isaia C; Sykioti P; Vadalouca A
Pain Physician; 2014; 17(2):E213-8. PubMed ID: 24658488
[TBL] [Abstract][Full Text] [Related]
33. [Effective pain relief of post-herpetic neuralgia with capsaicin patch].
Andersen HH; Sand C; Elberling J
Ugeskr Laeger; 2016 Feb; 178(5):V10150846. PubMed ID: 26857302
[TBL] [Abstract][Full Text] [Related]
34. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Aitken E; McColl G; Kingsmore D
Pain Med; 2017 Feb; 18(2):330-340. PubMed ID: 28204726
[TBL] [Abstract][Full Text] [Related]
35. Post-herpetic neuralgia and topical capsaicin.
Watson PNC; Evans RJ; Watt VR
Pain; 1988 Jun; 33(3):333-340. PubMed ID: 2458561
[TBL] [Abstract][Full Text] [Related]
36. Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency department: a case series.
Dezieck L; Hafez Z; Conicella A; Blohm E; O'Connor MJ; Schwarz ES; Mullins ME
Clin Toxicol (Phila); 2017 Sep; 55(8):908-913. PubMed ID: 28494183
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a reproducible gastric pain model using oral capsaicin titration in healthy volunteers.
Cao Y; Wilder-Smith CH; Li XH; Wong RK; Hammer J; Ho KY
Neurogastroenterol Motil; 2011 Jul; 23(7):e261-70. PubMed ID: 21679343
[TBL] [Abstract][Full Text] [Related]
38. Increased contact heat pain and shortened latencies of contact heat evoked potentials following capsaicin-induced heat hyperalgesia.
Madsen CS; Johnsen B; Fuglsang-Frederiksen A; Jensen TS; Finnerup NB
Clin Neurophysiol; 2012 Jul; 123(7):1429-36. PubMed ID: 22188747
[TBL] [Abstract][Full Text] [Related]
39. An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy.
Simpson DM; Estanislao L; Brown SJ; Sampson J
J Pain Symptom Manage; 2008 Mar; 35(3):299-306. PubMed ID: 17959343
[TBL] [Abstract][Full Text] [Related]
40. Reaction to topical capsaicin in spinal cord injury patients with and without central pain.
Finnerup NB; Pedersen LH; Terkelsen AJ; Johannesen IL; Jensen TS
Exp Neurol; 2007 May; 205(1):190-200. PubMed ID: 17346705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
